Minerva Neurosciences, Inc. Share Price: NERV (Minerva Neurosciences, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Minerva Neurosciences, Inc. share price today?

Accepted Answer

Minerva Neurosciences, Inc. (NERV) share price today is {{live_price}}.

Question 2

Can Indians buy Minerva Neurosciences, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Minerva Neurosciences, Inc. (NERV) from India.

With INDmoney, you can buy Minerva Neurosciences, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Minerva Neurosciences, Inc. at zero transaction cost.

Question 3

How can I buy Minerva Neurosciences, Inc. shares from India?

Accepted Answer

It is very easy to buy Minerva Neurosciences, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Minerva Neurosciences, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Minerva Neurosciences, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Minerva Neurosciences, Inc. stocks?

Accepted Answer

To start investing in Minerva Neurosciences, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Minerva Neurosciences, Inc.

Accepted Answer

Today’s highest price of Minerva Neurosciences, Inc. (NERV) is {{1_rba_end}}.

Today’s lowest price of Minerva Neurosciences, Inc. (NERV) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Minerva Neurosciences, Inc.

Accepted Answer

Today's market capitalisation of Minerva Neurosciences, Inc. NERV is 22.5M

Question 8

What is the 52 Week High and Low Range of Minerva Neurosciences, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Minerva Neurosciences, Inc. is down from its 52 Week High?

Accepted Answer

Minerva Neurosciences, Inc. (NERV) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Minerva Neurosciences, Inc. is up from its 52 Week low?

Accepted Answer

Minerva Neurosciences, Inc. (NERV) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Minerva Neurosciences, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Minerva Neurosciences, Inc.

Accepted Answer

Dr. Remy  Luthringer Ph.D. is the current Chief Executive Officer (CEO) of Minerva Neurosciences, Inc..

Period	Minerva Neurosciences, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	28.05%	6.5%	0.0%
6 Months	-61.67%	7.1%	0.0%
1 Year	-63.29%	9.8%	0.0%
3 Years	-79.37%	14.2%	-20.2%

Market Capitalization	22.5M
Book Value	- $5.23
Earnings Per Share (EPS)	-4.43
PEG Ratio	0.0
Wall Street Target Price	7.0

Profit Margin	0.0%
Operating Margin TTM	0.0%

Return On Assets TTM	-29.94%
Return On Equity TTM	-675.09%

Revenue TTM	0.0
Revenue Per Share TTM	0.0
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	-16.8M
EBITDA	-24.4M
Diluted Eps TTM	-4.43
Quarterly Earnings Growth YOY	0.0

Minerva Neurosciences, Inc. (NERV)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Vs NVO

Vs NVO

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-1.89
EPS Estimate Next Year	-3.6
EPS Estimate Current Quarter	-1.2
EPS Estimate Next Quarter	-0.77

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Minerva Neurosciences, Inc.	-0.95%	-61.67%	-63.29%	-79.37%	-93.98%
Moderna, Inc.	-1.67%	18.26%	-0.21%	-64.15%	752.69%
Regeneron Pharmaceuticals, Inc.	-0.46%	13.21%	45.59%	84.19%	244.2%
Novo Nordisk A/s	-11.0%	18.31%	61.56%	186.46%	423.59%
Vertex Pharmaceuticals Incorporated	3.85%	14.43%	39.88%	147.45%	195.07%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Minerva Neurosciences, Inc.	NA	NA	0.0	-1.89	-6.75	-0.3	NA	-5.23
Moderna, Inc.	24.73	NA	0.0	-7.19	-0.38	-0.16	NA	33.47
Regeneron Pharmaceuticals, Inc.	31.35	31.35	1.46	44.44	0.15	0.08	NA	250.15
Novo Nordisk A/s	44.28	44.28	2.36	3.43	1.0	0.25	0.01	22.18
Vertex Pharmaceuticals Incorporated	31.85	31.85	0.53	16.98	0.24	0.13	NA	71.8

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Minerva Neurosciences, Inc.	Sell	$22.5M	-93.98%	NA	0.0%
Moderna, Inc.	Buy	$45.3B	752.69%	24.73	-115.82%
Regeneron Pharmaceuticals, Inc.	Buy	$116.9B	244.2%	31.35	29.45%
Novo Nordisk A/s	Buy	$572.0B	423.59%	44.28	36.55%
Vertex Pharmaceuticals Incorporated	Buy	$126.7B	195.07%	31.85	39.46%

Organization	Minerva Neurosciences, Inc.
Employees	9
CEO	Dr. Remy Luthringer Ph.D.
Industry	Health Technology